SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-006509
Filing Date
2007-02-01
Accepted
2007-02-01 16:45:23
Documents
2
Period of Report
2007-02-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-3181_18k.htm 8-K 25276
2 EX-99.1 a07-3181_1ex99d1.htm EX-99.1 237852
  Complete submission text file 0001104659-07-006509.txt   264707
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19319 | Film No.: 07572340
SIC: 2834 Pharmaceutical Preparations